News Focus
News Focus
Followers 75
Posts 114271
Boards Moderated 3
Alias Born 08/01/2006

Re: dropdeadfred post# 369195

Thursday, 04/01/2021 11:35:44 PM

Thursday, April 01, 2021 11:35:44 PM

Post# of 579180
dropdeadfred - Your non-approval claim seems to be blatantly false.

Q&A on COVID-19 Vaccines

By Jessica McDonald

Posted on December 18, 2020 | Updated on April 1, 2021

Three COVID-19 vaccines are now authorized in the U.S. and more are likely to follow. In this story, we answer some common questions about the shots.

For more information about specific vaccines, we’ve created or will be creating individual pages for COVID-19 vaccines that are authorized or likely to be authorized.

The first vaccine that received the Food and Drug Administration’s green light was Pfizer/BioNTech’s two-dose mRNA vaccine, which was authorized via an emergency use authorization, or EUA, on Dec. 11. (For more, please see “A Guide to Pfizer/BioNTech’s COVID-19 Vaccine.”)

Close behind was Moderna’s vaccine, which also uses an mRNA platform and got the same nod on Dec. 18. A day earlier, the FDA advisory committee voted 20-0, with one abstention, that the vaccine’s benefits outweigh the risks for use in people 18 years of age and older. Moderna announced on Nov. 30 that its product had a 94% efficacy in preventing symptomatic disease in its phase 3 trial. (See “A Guide to Moderna’s COVID-19 Vaccine” for more.)

On Feb. 27, the one-shot vaccine from Janssen Biotech Inc., a Johnson & Johnson pharmaceutical company, was authorized by the FDA. Unlike the first two vaccines authorized in the U.S., the J&J vaccine uses adenovirus viral vector technology. (See “A Guide to Johnson & Johnson’s COVID-19 Vaccine.”)

More - https://www.factcheck.org/2020/12/qa-on-covid-19-vaccines/

It was Plato who said, “He, O men, is the wisest, who like Socrates, knows that his wisdom is in truth worth nothing”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today